Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fridtjof Jerve

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|February 18, 2005
Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decadeIngvil Krarup Sørbye, Fridtjof Jerve, Anne Cathrine Staff
BJOG : an International Journal of Obstetrics and Gynaecology|January 16, 2004
The use of oral misoprostol for pre-abortion cervical priming: a randomised controlled trial of 400 versus 200 microg in first trimester pregnanciesKevin S Oppegaard, Mikael Abdelnoor, Britt-Ingjerd Nesheim, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 27, 2007
[Induced abortion at home]Hilde Jørgensen, Erik Qvigstad, Fridtjof Jerve, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 9, 2002
[Induced abortion among women with foreign cultural background in Oslo]Anne Eskild, Linda Bjørk Helgadottir, Fridtjof Jerve, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 17, 2004
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortionHelena Honkanen, Gilda Piaggio, Helena Hertzen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 27, 2003
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: EfficacyHelena von Hertzen, Helena Honkanen, Gilda Piaggio, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Acta Obstetricia Et Gynecologica Scandinavica|February 18, 2005
Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decadeIngvil Krarup Sørbye, Fridtjof Jerve, Anne Cathrine Staff
BJOG : an International Journal of Obstetrics and Gynaecology|January 16, 2004
The use of oral misoprostol for pre-abortion cervical priming: a randomised controlled trial of 400 versus 200 microg in first trimester pregnanciesKevin S Oppegaard, Mikael Abdelnoor, Britt-Ingjerd Nesheim, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 27, 2007
[Induced abortion at home]Hilde Jørgensen, Erik Qvigstad, Fridtjof Jerve, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 9, 2002
[Induced abortion among women with foreign cultural background in Oslo]Anne Eskild, Linda Bjørk Helgadottir, Fridtjof Jerve, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 17, 2004
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortionHelena Honkanen, Gilda Piaggio, Helena Hertzen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 27, 2003
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: EfficacyHelena von Hertzen, Helena Honkanen, Gilda Piaggio, et al.
Pageof 1